Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)

118 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share as of Q3 2024.
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 179M shares of 266M outstanding shares and own 67.09% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (24.2M shares), Blackstone Inc. (20.5M shares), Syncona Portfolio Ltd (18.6M shares), FMR LLC (17.8M shares), Deep Track Capital, LP (15.3M shares), Avoro Capital Advisors LLC (12.3M shares), TFG Asset Management GP Ltd (8M shares), ARMISTICE CAPITAL, LLC (6.87M shares), Frazier Life Sciences Management, L.P. (4.62M shares), and Affinity Asset Advisors, LLC (4.5M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.